A. Sampériz

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules

Fatal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: findings from the RIETE registry

Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Evidence-Based Management of Anticoagulant Therapy

Factors at Admission Associated With Bleeding Risk in Medical Patients

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study

Perioperative Management of Antithrombotic Therapy

Oral Anticoagulant Therapy

Antithrombotic Therapy for VTE Disease

Prevention of VTE in Nonsurgical Patients

Pulmonary embolism and deep vein thrombosis

Antithrombotic Therapy for VTE Disease

Executive Summary

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

Clinical performance of bleeding risk scores for predicting major and clinically relevant non‐major bleeding events in patients receiving warfarin

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

Thrombosis as an intravascular effector of innate immunity

Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Guidelines for the Primary Prevention of Stroke

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension

Worldwide Epidemiology of Atrial Fibrillation

Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation

Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage

Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry

Clinical outcome of patients with venous thromboembolism and recent major bleeding: findings from a prospective registry (RIETE)